Diuretic use and duration of home oxygen therapy in infants with Bronchopulmonary Dysplasia (BPD)

2019 ◽  
Author(s):  
Yung Ci Chai ◽  
Jayesh M. Bhatt
Keyword(s):  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
Home Oxygen Therapy

Duration of home oxygen therapy and postnatal catch-up growth in bronchopulmonary dysplasia

2020 ◽  
Author(s):  
Manisha Ramphul ◽  
Anna Poghosyan ◽  
Dushyant Batra ◽  
Andrew Prayle ◽  
Jayesh M Bhatt
Keyword(s):  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
Home Oxygen Therapy ◽  
Catch Up

Home oxygen therapy in infants with bronchopulmonary dysplasia: a prospective study

1997 ◽  
Vol 156 (11) ◽  
pp. 878-882 ◽  
Author(s):  
E. Baraldi ◽  
S. Carrǎ ◽  
F. Vencato ◽  
M. Filippone ◽  
D. Trevisanuto ◽  
...  
Keyword(s):  
Prospective Study ◽  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
Home Oxygen Therapy ◽  
A Prospective Study

scholarly journals Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial

2021 ◽  
Vol 49 (1) ◽  
pp. 104-110
Author(s):  
Anne Greenough ◽  
Fabrice Decobert ◽  
David Field ◽  
Mikko Hallman ◽  
Helmut D. Hummler ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Bronchopulmonary Dysplasia ◽  
Premature Infants ◽  
Oxygen Therapy ◽  
Well Being ◽  
Inhaled Nitric Oxide ◽  
Current Evidence ◽  
Home Oxygen Therapy

AbstractObjectivesMost studies of inhaled nitric oxide (iNO) for prevention of bronchopulmonary dysplasia (BPD) in premature infants have focused on short-term mortality and morbidity. Our aim was to determine the long-term effects of iNO.MethodsA 7-year follow-up was undertaken of infants entered into a multicenter, double-blind, randomized, placebo-controlled trial of iNO for prevention of BPD in premature infants born between 24 and 28 weeks plus six days of gestation. At 7 years, survival and hospital admissions since the 2-year follow-up, home oxygen therapy in the past year, therapies used in the previous month and growth assessments were determined. Questionnaires were used to compare general health, well-being, and quality of life.ResultsA total of 305 children were assessed. No deaths were reported. Rates of hospitalization for respiratory problems (6.6 vs. 10.5%, iNO and placebo group, respectively) and use of respiratory medications (6.6 vs. 9.2%) were similar. Two patients who received iNO and one who received placebo had received home oxygen therapy. There were no significant differences in any questionnaire-documented health outcomes.ConclusionsiNO for prevention of BPD in very premature infants with respiratory distress did not result in long-term benefits or adverse long-term sequelae. In the light of current evidence, routine use of iNO cannot be recommended for prevention of BPD in preterm infants.

scholarly journals Retrospective analysis of inpatient polysomnogram characteristics and discharge outcomes in infants with bronchopulmonary dysplasia requiring home oxygen therapy

2020 ◽  
Vol 56 (1) ◽  
pp. 88-96
Author(s):  
Nicole Flores‐Fenlon ◽  
Noah Wright ◽  
Cheryl Lew ◽  
Theodora A. Stavroudis ◽  
Choo Phei Wee ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Bronchopulmonary Dysplasia ◽  
Oxygen Therapy ◽  
Home Oxygen Therapy ◽  
Discharge Outcomes

scholarly journals Oxigenoterapia Domiciliária de Longa Duração na Criança: Evidências e Questões em Aberto

2014 ◽  
Vol 27 (6) ◽  
pp. 717 ◽  
Author(s):  
Lia Oliveira ◽  
Joana Coelho ◽  
Rosário Ferreira ◽  
Teresa Nunes ◽  
Ana Saianda ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Bronchopulmonary Dysplasia ◽  
Bronchiolitis Obliterans ◽  
Lung Diseases ◽  
Oxygen Therapy ◽  
Pediatric Population ◽  
Home Oxygen Therapy ◽  
Neonatal Lung

<strong>Introduction:</strong> Long-term home oxygen therapy is indicated for patients with chronic hypoxemia. We intend to describe pediatric population on long-term home oxygen therapy followed-up at Pediatric Respiratory Unit of a tertiary care hospital between 2003-2012 and to compare with previous 1991-2000 review; to verify conformity with international and national recommendations and need for specific pediatric national guidelines, non-existent in Portugal.<br /><strong>Material and Methods:</strong> Retrospective, descriptive and comparative study based on clinical files review. Review the guidelines for oxygen therapy in pediatric population.<br /><strong>Results:</strong> We studied 86 patients (59.3% males). The median age at the beginning of oxygen therapy was 0.0 (0.0-216.0) months, with a median duration of 15.0 (3.0-223.0) months. The most frequent diagnosis was bronchopulmonary dysplasia (53.5%), followed by bronchiolitis obliterans (14.0%), neurologic disorders (10.5%), cystic fibrosis (8.1%), miscellaneous syndromes (5.8%), sickle-cell disease (3.5%), other neonatal lung diseases (2.3%) and interstitial lung diseases (2.3%). Are maintained on follow-up 53 (61.6%) patients, 38 on oxygen therapy; 12 (13.9%) died. The median time of follow-up was 39.5 (1.0-246.0) months, minim on other neonatal lung diseases and maximum on cystic fibrosis. Comparing with previous review, this shows a relative increase in bronchiolitis obliterans and bronchopulmonary dysplasia patients, with increased duration in the latter, and inclusion of neurologic and hematologic patients.<br /><strong>Discussion:</strong> Prescription of long-term oxygen therapy in pediatric age mainly occurs in specific diseases of infants and pre-school aged. Neurologic and hematologic patients represent new indications, similarly to international publications.<br /><strong>Conclusion:</strong> The knowledge of national reality and pediatric orientations are needed for care plans and rational prescription.<br /><strong>Keywords:</strong> Child; Long-Term Care; Respiratory Insufficiency; Oxygen Inhalation Therapy; Portugal.

scholarly journals LOWER RESPIRATORY TRACT LESION CAUSED BY INFLUENZA A IN AN OXYGENDEPENDENT CHILD WITH BRONCHOPULMONARY DYSPLASIA

2020 ◽  
Vol 3 (25(52)) ◽  
pp. 14-15
Author(s):  
Zoya Viktorovna Zyukina ◽  
Irina Vladimirovna Krsheminskaya ◽  
Shamil Abdulgamidovich Gitinov
Keyword(s):  
Bronchopulmonary Dysplasia ◽  
Influenza A ◽  
Oxygen Therapy ◽  
Very Low Birth Weight ◽  
Respiratory Infections ◽  
First Year ◽  
Home Oxygen Therapy ◽  
Flu Virus ◽  
Syncytial Virus ◽  
First Year Of Life

The relevance of the study is due to the fact that bronchopulmonary dysplasia (bpd) is the most common chronic lung disease in children under 3 years of age. The frequency of BPD in children with very low birth weight is 18-76%. Infants with BPD are more likely to be rehospitalized during the first year of life, especially in connection with respiratory infections, which occupy the 1st place in the structure of morbidity in children under 14 years of age. The main reason for repeated hospitalizations of children with BPD is respiratory infections caused by the respiratory syncytial virus and the flu virus. 63% of children with BPD are re-admitted due to respiratory diseases, one of the risk factors for re-hospitalizations is home oxygen therapy (the frequency of hospitalization due to respiratory infections in this group of children is 58%, in children who do not require home oxygen therapy – 18%)

Sign in / Sign up

Export Citation Format

Share Document